Exact Mass: 665.1371

Exact Mass Matches: 665.1371

Found 33 metabolites which its exact mass value is equals to given mass value 665.1371, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

1,4-Dihydronicotinamide adenine dinucleotide

Dihydronicotinamide-adenine dinucleotide

C21H29N7O14P2 (665.1248)


Nicotinamide adenine dinucleotide (NAD) is a coenzyme central to metabolism. Found in all living cells, NAD is called a dinucleotide because it consists of two nucleotides joined through their phosphate groups. One nucleotide contains an adenine nucleobase and the other nicotinamide. NAD exists in two forms: an oxidized and reduced form, abbreviated as NAD+ and NADH (H for hydrogen) respectively. NADH is the reduced form of NAD+, and NAD+ is the oxidized form of NADH. NAD (or nicotinamide adenine dinucleotide) is used extensively in glycolysis and the citric acid cycle of cellular respiration. The reducing potential stored in NADH can be either converted into ATP through the electron transport chain or used for anabolic metabolism. ATP "energy" is necessary for an organism to live. Green plants obtain ATP through photosynthesis, while other organisms obtain it via cellular respiration. NAD is a coenzyme composed of ribosylnicotinamide 5-diphosphate coupled to adenosine 5-phosphate by a pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). NADP is formed through the addition of a phosphate group to the 2 position of the adenosyl nucleotide through an ester linkage. NADH is the reduced form of NAD+, and NAD+ is the oxidized form of NADH, A coenzyme composed of ribosylnicotinamide 5-diphosphate coupled to adenosine 5-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). It forms NADP with the addition of a phosphate group to the 2 position of the adenosyl nucleotide through an ester linkage.(Dorland, 27th ed) [HMDB]. NADH is found in many foods, some of which are dill, ohelo berry, fox grape, and black-eyed pea. Acquisition and generation of the data is financially supported in part by CREST/JST. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Nicotinic acid adenine dinucleotide

1-[(2R,3R,4S,5R)-5-[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-3,4-dihydroxyoxolan-2-yl]-3-carboxy-1lambda5-pyridin-1-ylium

[C21H27N6O15P2]+ (665.101)


Nicotinic acid adenine dinucleotide, also known as deamido-NAD or NAAD, belongs to the class of organic compounds known as (5->5)-dinucleotides. These are dinucleotides where the two bases are connected via a (5->5)-phosphodiester linkage. NAAD is possibly soluble (in water) and a strong basic compound (based on its pKa). NAAD exists in all living species, ranging from bacteria to humans. L-Glutamine and NAAD can be converted into L-glutamic acid and NAD; which is catalyzed by the enzyme glutamine-dependent nad(+) synthetase. In humans, NAAD is involved in the nicotinate and nicotinamide metabolism pathway. NAAD is also involved in the metabolic disorder called succinic semialdehyde dehydrogenase deficiency. Outside of the human body, NAAD has been detected, but not quantified in, several different foods, such as japanese walnuts, cauliflowers, sparkleberries, komatsuna, and macadamia nut (m. tetraphylla). This could make NAAD a potential biomarker for the consumption of these foods. NAAD is the product of the degradation of Nicotinic acid adenine dinucleotide phosphate (NAADP) by a Ca2+-sensitive phosphatase. NAADP is a Ca2+-mobilizing second messenger which is synthesized, in response to extracellular stimuli, via the base-exchange reaction by an ADP-ribosyl cyclase (ARC) family members (such as CD38). NAADP binds to and opens Ca2+ channels on intracellular organelles, thereby increasing the intracellular Ca2+ concentration which, in turn, modulates a variety of cellular processes. Structurally, NAADP it is a dinucleotide that only differs from the house-keeping enzyme cofactor, NADP, by a hydroxyl group (replacing the nicotinamide amino group) and yet this minor modification converts it into the most potent Ca2+-mobilizing second messenger yet described. NAADP may also be broken down to 2-phosphoadenosine diphosphoribose (ADPRP) by CD38 or reduced to NAADPH. Deamido-nad(+), also known as deamidonicotinamide adenine dinucleoetide, is a member of the class of compounds known as (5->5)-dinucleotides (5->5)-dinucleotides are dinucleotides where the two bases are connected via a (5->5)-phosphodiester linkage. Deamido-nad(+) is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Deamido-nad(+) can be found in a number of food items such as garden tomato, sea-buckthornberry, pitanga, and japanese walnut, which makes deamido-nad(+) a potential biomarker for the consumption of these food products. Deamido-nad(+) exists in all living species, ranging from bacteria to humans. In humans, deamido-nad(+) is involved in few metabolic pathways, which include glutamate metabolism, homocarnosinosis, and nicotinate and nicotinamide metabolism. Deamido-nad(+) is also involved in few metabolic disorders, which include 2-hydroxyglutric aciduria (D and L form), 4-hydroxybutyric aciduria/succinic semialdehyde dehydrogenase deficiency, hyperinsulinism-hyperammonemia syndrome, and succinic semialdehyde dehydrogenase deficiency.

   

Nicotinamide hypoxanthine dinucleotide

Nicotinamide hypoxanthine dinucleotide

C21H27N6O15P2+ (665.101)


   

2-hydro-beta-NAD

1,2-Dihydro-beta-NAD

C21H29N7O14P2 (665.1248)


An NADP obtained by formal reduction of the 1,2-position in the pyridine ring of beta-NAD.

   

6-hydro-beta-NAD

1,6-Dihydro-beta-NAD

C21H29N7O14P2 (665.1248)


An NADP obtained by formal reduction of the 1,6-position in the pyridine ring of beta-NAD.

   
   

Pelargonidin 3-O-[2-O-(beta-D-xylopyranosyl)-6-O-(methyl-malonyl)-bata-D-galactopyranoside]

Pelargonidin 3-O-[2-O-(beta-D-xylopyranosyl)-6-O-(methyl-malonyl)-bata-D-galactopyranoside]

C30H33O17 (665.1718)


   

NADH

beta-nicotinamide adenine Dl-nucleotide ,reduced dipotassium salt

C21H29N7O14P2 (665.1248)


A coenzyme found in all living cells; consists of two nucleotides joined through their 5-phosphate groups, with one nucleotide containing an adenine base and the other containing nicotinamide. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Pelargonidin 3-O-[2-O-(beta-D-xylopyranosyl)-6-O-(methyl-malonyl)-beta-D-galactopyranoside]

Pelargonidin 3-O-[2-O-(beta-D-xylopyranosyl)-6-O-(methyl-malonyl)-beta-D-galactopyranoside]

C30H33O17 (665.1718)


   
   
   
   
   

6-O-malonylnaringin

6-O-malonylnaringin

C30H33O17- (665.1718)


   

[[(2R,3S,4R,5R)-5-(5-acetyl-2,5-dihydropyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate

[[(2R,3S,4R,5R)-5-(5-acetyl-2,5-dihydropyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate

C22H31N6O14P2+ (665.1373)


   

[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl] hydrogen phosphate

[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl] hydrogen phosphate

C18H29N5O18P2 (665.0983)


   

S-methyl 5-hydroxy-6-[4-hydroxy-6-(5-hydroxy-6-methoxy-1H-indole-2-carbonyl)-3,6-dihydropyrrolo[3,2-e]indole-2-carbonyl]-4-methoxy-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-2-carbothioate

S-methyl 5-hydroxy-6-[4-hydroxy-6-(5-hydroxy-6-methoxy-1H-indole-2-carbonyl)-3,6-dihydropyrrolo[3,2-e]indole-2-carbonyl]-4-methoxy-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-2-carbothioate

C34H27N5O8S (665.158)


   

Pelargonidin 3-O-[2-O-(beta-D-xylopyranosyl)-6-O-(methyl-malonyl)-bata-D-galactopyranoside]

Pelargonidin 3-O-[2-O-(beta-D-xylopyranosyl)-6-O-(methyl-malonyl)-bata-D-galactopyranoside]

C30H33O17+ (665.1718)


   

N-acetyl-beta-D-galactosaminyl-(1->6)-[6-O-sulfonato-beta-D-glucosyl-(1->3)]-N-acetyl-beta-D-galactosamine

N-acetyl-beta-D-galactosaminyl-(1->6)-[6-O-sulfonato-beta-D-glucosyl-(1->3)]-N-acetyl-beta-D-galactosamine

C22H37N2O19S- (665.1711)


   

6-[(2Z)-2-[(Z)-3-[3-(5-carboxypentyl)-6-sulfo-1,3-benzoxazol-3-ium-2-yl]prop-2-enylidene]-6-sulfo-1,3-benzoxazol-3-yl]hexanoic acid

6-[(2Z)-2-[(Z)-3-[3-(5-carboxypentyl)-6-sulfo-1,3-benzoxazol-3-ium-2-yl]prop-2-enylidene]-6-sulfo-1,3-benzoxazol-3-yl]hexanoic acid

C29H33N2O12S2+ (665.1475)


   

Deaminocozymase

Deaminocozymase

C21H27N6O15P2+ (665.101)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   
   

Nicotinic acid adenine dinucleotide

Nicotinic acid adenine dinucleotide

C21H27N6O15P2+ (665.101)


   
   

YTM-T

YTM-T

C34H27N5O8S (665.158)


A member of the class of pyrroloindoles that is an intermediate in the biosynthesis of yatakemycin by Streptomyces sp. TP-A0356

   

Nicotinamide purin-6-ol-dinucleotide

Nicotinamide purin-6-ol-dinucleotide

C21H27N6O15P2 (665.101)


   

Mesdopetam (hemitartrate)

Mesdopetam (hemitartrate)

C12H18FNO3S.1/2C4H6O6 (665.1156)


Mesdopetam (IRL790) hemitartrate is a dopamine D3 receptor antagonist (Ki=90 nM; IC50=9.8 μM for human recombinant D3 receptor) with psychomotor stabilizing properties. Mesdopetam hemitartrate is used for the research of motor and psychiatric complications in Parkinson disease[1][2].

   

3-{[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-{[(3-methoxy-3-oxopropanoyl)oxy]methyl}-3-{[(2r,3r,4r,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxyphenyl)-1λ⁴-chromen-1-ylium

3-{[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-{[(3-methoxy-3-oxopropanoyl)oxy]methyl}-3-{[(2r,3r,4r,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxyphenyl)-1λ⁴-chromen-1-ylium

[C30H33O17]+ (665.1718)


   

(13r,16r,19s,22r)-16-benzyl-19-[(2s)-butan-2-yl]-22-methyl-3,7,11,24-tetrathia-15,18,21,26,27,28,29-heptaazapentacyclo[21.2.1.1²,⁵.1⁶,⁹.1¹⁰,¹³]nonacosa-1(25),2(29),4,6(28),8,10(27),14,17,20,23(26)-decaene-14,17,20-triol

(13r,16r,19s,22r)-16-benzyl-19-[(2s)-butan-2-yl]-22-methyl-3,7,11,24-tetrathia-15,18,21,26,27,28,29-heptaazapentacyclo[21.2.1.1²,⁵.1⁶,⁹.1¹⁰,¹³]nonacosa-1(25),2(29),4,6(28),8,10(27),14,17,20,23(26)-decaene-14,17,20-triol

C30H31N7O3S4 (665.1371)


   

1-[(2r,3r,4s,5r)-5-{[({[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-4h-pyridine-3-carboximidic acid

1-[(2r,3r,4s,5r)-5-{[({[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-4h-pyridine-3-carboximidic acid

C21H29N7O14P2 (665.1248)


   

16-benzyl-22-methyl-19-(sec-butyl)-3,7,11,24-tetrathia-15,18,21,26,27,28,29-heptaazapentacyclo[21.2.1.1²,⁵.1⁶,⁹.1¹⁰,¹³]nonacosa-1(25),2(29),4,6(28),8,10(27),14,17,20,23(26)-decaene-14,17,20-triol

16-benzyl-22-methyl-19-(sec-butyl)-3,7,11,24-tetrathia-15,18,21,26,27,28,29-heptaazapentacyclo[21.2.1.1²,⁵.1⁶,⁹.1¹⁰,¹³]nonacosa-1(25),2(29),4,6(28),8,10(27),14,17,20,23(26)-decaene-14,17,20-triol

C30H31N7O3S4 (665.1371)


   

1-[(2r,3s,4r,5r)-5-{[({[(2s,3s,4s,5s)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-4h-pyridine-3-carboximidic acid

1-[(2r,3s,4r,5r)-5-{[({[(2s,3s,4s,5s)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-4h-pyridine-3-carboximidic acid

C21H29N7O14P2 (665.1248)